Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and pericervical tourniquet for reducing blood loss in open abdominal myomectomy
PACTR202404508588938Completed
- Sponsor
- Lubabatu
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid in Fibromyoma (LM) (4 arms), sponsored by Lubabatu. Primary endpoint: Level of blood loss. Started Jun 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202404508588938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404508588938.